Defence technology group QinetiQ (LSE:QQ.) has completed the third £50 million Tranche of its share buyback and started a fourth tranche of up to £50 million, to be executed by Barclays by 31 March 2027. The new tranche forms part of the existing £200 million programme and is not a new authorisation.

Third tranche completed, fourth begins

QinetiQ Group plc (LSE:QQ.) announced on 28 September 2026 that the third tranche of its share buyback programme, worth £50 million, had been completed. That tranche was carried out by Deutsche Bank AG, London Branch, trading as Deutsche Numis. The announcement did not disclose how many shares were bought back under the third tranche or the average price paid.

The company has now commenced a fourth tranche of up to £50 million. It will be executed by Barclays Bank PLC, acting through its Investment bank, from the date of the announcement until no later than 31 March 2027. Barclays will act as riskless principal and will make trading decisions independently of the company, including during closed periods.

The maximum number of shares that may be purchased under the fourth tranche is 49,575,634 ordinary shares, the number remaining under the authority granted by shareholders at QinetiQ's Annual General Meeting on 16 July 2026. All shares bought will be cancelled and the number of ordinary shares in issue reduced accordingly. The company said the sole purpose of the programme is to reduce its share capital.

The purchases will be conducted in line with the UK Listing Rules, the UK version of the Market Abuse Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) 2016/1052 as retained in UK law. Individual purchases will be reported through the company's regular "Transaction in Own Shares" announcements.

The wider programme

The fourth tranche sits within a £200 million extension to QinetiQ's buyback, which the company announced on 17 March 2025 and intended to execute over two years. The 28 September announcement is therefore the start of a new tranche under an existing programme and existing Shareholder authority, rather than the approval of a new buyback.

In its first-quarter trading update on 16 July 2026, QinetiQ said it had completed £32.0 million of share Buybacks during the quarter and that about £68 million of the current programme remained, with completion expected by the end of its 2027 financial year. The fourth tranche's end date of 31 March 2027 is consistent with that timetable. In the same update, the company said a new £200 million programme would commence thereafter. The 28 September announcement did not provide further detail on that later programme.

Trading backdrop

The July update said trading in the first quarter had been "consistent with full-year expectations", supported by a record opening order Backlog and the UK Defence Investment Plan published on 30 June 2026. For the financial year to March 2027, QinetiQ guided to Revenue growth of 3% to 5%, an underlying operating profit Margin of 11.0% to 11.5%, Earnings Per Share growth of 8% to 10% and cash conversion above 90%. It also set a free Cash Flow target of more than £550 million across the 2027 to 2029 financial years.

Chief Executive Steve Wadey said in July: "The UK Defence Investment Plan and the NATO Summit reinforce the urgency to transform warfighting capabilities at pace." The company said it has direct exposure to priorities in the plan, including test and evaluation, mission systems integration, Training and readiness, and digital capability.

Next update

QinetiQ is scheduled to publish interim results on 12 November 2026, when it said it would also provide an update on its review of its US business. The buyback announcement itself contained no new financial information or changes to guidance.